InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
5
T+90 hit rate
67%
T+90 mean return
-5.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by MOYES JAY M, Director. Insider active across 2 companies, notably Puma Biotechnology, INC.. In total, 12 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €667k. History available since 10 June 2021. The latest transaction was disclosed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
27,000 shares0Common StockSEC:0001437749-24-021016:0
22,000 shares@ US$3.339410.3% of flowCommon StockSEC:0001437749-24-020568:0
22,000 shares@ US$3.453210.6% of flowCommon StockSEC:0001437749-23-017610:0
32,800 shares0Class A Common StockSEC:0001534969-23-000017:0
22,858 shares@ US$2.64110.016% mcap10.8% of flowCommon StockSEC:0001437749-22-015524:0
27,000 shares0Common StockSEC:0001437749-22-015294:0
2,455 sharesClass A Common StockSEC:0001104659-21-094520:0
2,455 sharesClass A Common StockSEC:0001104659-21-094520
27,858 shares0Common StockSEC:0001209191-21-041706
27,858 shares0Common StockSEC:0001209191-21-041706:0
25,248 shares@ US$11.36170.067% mcap44.6% of flowCommon StockSEC:0001209191-21-039954:0
25,248 shares@ US$11.361735.3% of flowCommon StockSEC:0001209191-21-039954
12 of 12 declarations
About MOYES JAY M
MOYES Jay M serves as a Board Member and Chief Financial Officer of Puma Biotechnology, Inc. and Sera Prognostics, Inc. He plays a key role in overseeing the finances and strategy of the companies, ensuring transparency and financial accountability. His financial expertise is an asset to the boards.
